- Home
- EVGOW vs LYEL Comparison
EVGOW vs LYEL Comparison
Compare EVGOW & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EVGOW | LYEL |
|---|---|---|
| Founded | 2010 | 2018 |
| Country | United States | United States |
| Employees | 331 | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 745.5M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | EVGOW | LYEL |
|---|---|---|
| Price | $0.06 | $31.68 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $25.00 |
| AVG Volume (30 Days) | 74.7K | ★ 105.8K |
| Earning Date | 03-07-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $239,306,000.00 | $41,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 73.08 | N/A |
| 52 Week Low | $0.12 | $7.65 |
| 52 Week High | $1.99 | $45.00 |
Technical Indicators
Market Signals| Indicator | EVGOW | LYEL |
|---|---|---|
| Relative Strength Index (RSI) | 29.52 | 53.64 |
| Support Level | $0.06 | $32.01 |
| Resistance Level | $0.08 | $45.00 |
| Average True Range (ATR) | 0.01 | 3.53 |
| MACD | -0.00 | -0.30 |
| Stochastic Oscillator | 14.42 | 14.78 |
Price Performance
Historical ComparisonAbout EVGOW EVgo Inc.
EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.